Chembio Diagnostics, Inc.

Symbol: CEMI

NASDAQ

0.455

USD

Market price today

  • -1.2031

    P/E Ratio

  • 0.0111

    PEG Ratio

  • 16.71M

    MRK Cap

  • 0.00%

    DIV Yield

Chembio Diagnostics, Inc. (CEMI) Stock Price & Analysis

Shares Outstanding

36.73M

Gross Profit Margin

0.25%

Operating Profit Margin

-0.45%

Net Profit Margin

-0.45%

Return on Assets

-0.15%

Return on Equity

-0.52%

Return on Capital Employed

-0.39%

Company general description and statistics

Sector: Healthcare
Industry: Diagnostics & Research
CEO:Mr. Richard L. Eberly
Full-time employees:188
City:Hauppauge
Address:555 Wireless Boulevard
IPO:2000-10-18
CIK:0001092662

Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, rickettsia, and Burkholderia diseases. The company sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, and DPP trademarks, as well as sells its products directly through distributors to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. It has collaboration agreements with Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics, as well as U.S. government agencies, such as Centers for Disease Control and Prevention, the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services, and the U.S. Department of Agriculture. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Hauppauge, New York.

General Outlook

In simple terms, Chembio Diagnostics, Inc. has 36.726 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.250% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.451%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.451%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.147% return, is a testament to Chembio Diagnostics, Inc.'s adeptness in optimizing resource deployment. Chembio Diagnostics, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.516%. Furthermore, the proficiency of Chembio Diagnostics, Inc. in capital utilization is underscored by a remarkable -0.394% return on capital employed.

Stock Prices

Chembio Diagnostics, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.4497, while its low point bottomed out at $0.4467. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Chembio Diagnostics, Inc.'s stock market.

Liquidity Ratios

Analyzing CEMI liquidity ratios reveals its financial health of the firm. The current ratio of 123.29% gauges short-term asset coverage for liabilities. The quick ratio (93.90%) assesses immediate liquidity, while the cash ratio (46.26%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio123.29%
Quick Ratio93.90%
Cash Ratio46.26%

Profitability Ratios

CEMI profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -36.96% underscores its earnings before tax deductions. The effective tax rate stands at -22.10%, revealing its tax efficiency. The net income per EBT, 122.10%, and the EBT per EBIT, 82.01%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -45.07%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-36.96%
Effective Tax Rate-22.10%
Net Income per EBT122.10%
EBT per EBIT82.01%
EBIT per Revenue-45.07%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.23, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding94
Days of Inventory Outstanding184
Operating Cycle520.07
Days of Payables Outstanding80
Cash Conversion Cycle440
Receivables Turnover1.09
Payables Turnover4.57
Inventory Turnover1.98
Fixed Asset Turnover1.48
Asset Turnover0.33

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.32, and free cash flow per share, -0.34, depict cash generation on a per-share basis. The cash per share value, 0.75, showcases liquidity position. Lastly, the operating cash flow sales ratio, -0.39, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share-0.32
Free Cash Flow per Share-0.34
Cash per Share0.75
Operating Cash Flow Sales Ratio-0.39
Free Cash Flow to Operating Cash Flow Ratio1.04
Cash Flow Coverage Ratio-0.31
Short Term Coverage Ratio-0.40
Capital Expenditure Coverage Ratio-24.98
Dividend Paid and Capex Coverage Ratio-24.98

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 40.06%, highlights its total liabilities relative to assets. With a debt-equity ratio of 1.41, we discern the balance between debt and equity financing. The long-term debt to capitalization, 23.65%, and total debt to capitalization, 58.49%, ratios shed light on its capital structure. An interest coverage of -24.02 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio40.06%
Debt Equity Ratio1.41
Long Term Debt to Capitalization23.65%
Total Debt to Capitalization58.49%
Interest Coverage-24.02
Cash Flow to Debt Ratio-0.31
Company Equity Multiplier3.52

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 1.99, provides a glimpse into top-line earnings distributed across each share. Net income per share, -0.96, reflects the portion of profit attributed to each share. The book value per share, 0.73, represents the net asset value distributed per share, while the tangible book value per share, 0.73, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share1.99
Net Income Per Share-0.96
Book Value Per Share0.73
Tangible Book Value Per Share0.73
Shareholders Equity Per Share0.73
Interest Debt Per Share1.05
Capex Per Share-0.06

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 12,241,958.461, captures the company's total value, considering both debt and equity. Income quality, 0.55, assesses the reliability of reported earnings.

cards.indicatorcards.value
Enterprise Value12,241,958.461
Income Quality0.55
Research and Development to Revenue14.62%
Capex to Operating Cash Flow11.43%
Capex to Revenue-3.00%
Capex to Depreciation-56.84%
Stock-Based Compensation to Revenue4.76%
Graham Number3.97
Return on Tangible Assets-37.20%
Graham Net Net-0.36
Working Capital9,151,579
Tangible Asset Value17,798,357
Net Current Asset Value3,638,647
Invested Capital1
Average Receivables15,081,922
Average Payables5,544,259
Average Inventory10,317,932
Days Sales Outstanding141
Days Payables Outstanding32
Days of Inventory On Hand73
ROIC-41.38%
ROE-1.31%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.62, and the price to book ratio, 0.62, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.82, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -2.04, and price to operating cash flows, -1.40, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio0.62
Price to Book Ratio0.62
Price to Sales Ratio0.82
Price Cash Flow Ratio-1.40
Price Earnings to Growth Ratio0.01
Enterprise Value Multiple-1.28
Price Fair Value0.62
Price to Operating Cash Flow Ratio-1.40
Price to Free Cash Flows Ratio-2.04
Price to Tangible Book Ratio0.30
Enterprise Value to Sales0.25
Enterprise Value Over EBITDA-0.84
EV to Operating Cash Flow-0.96
Earnings Yield-436.27%
Free Cash Flow Yield-264.96%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Chembio Diagnostics, Inc. (CEMI) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -1.203 in 2024.

What is the ticker symbol of Chembio Diagnostics, Inc. stock?

The ticker symbol of Chembio Diagnostics, Inc. stock is CEMI.

What is company IPO date?

IPO date of Chembio Diagnostics, Inc. is 2000-10-18.

What is company current share price?

Current share price is 0.455 USD.

What is stock market cap today?

The market cap of stock today is 16710285.000.

What is PEG ratio in 2024?

The current 0.011 is 0.011 in 2024.

What is the number of employees in 2024?

In 2024 the company has 188.